semaglutide for alzheimer's An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of disease in closely watched trials, Novo Nordisk said. https://cnn.it/4ohnWx8 GLP-1 Drug Fails to Improve

Avoid lying down immediately after eating to help prevent acid reflux

Health authorities around the globe issue warnings about fake Ozempic

At the molecular level, the mechanism has been structurally resolved by NMR spectroscopy (Nature Communications, 2025): FOXO4-DRI binds to the disordered p53 TAD2 domain and forms a transiently folded complex through both the FOXO4-derived peptide region and its cationic cell permeability element

It interacts with multiple systems in the body including the nitric oxide (NO) pathway, growth hormone receptors, and angiogenic regulators like VEGF (vascular endothelial growth factor) to promote tissue repair, reduce oxidative stress, and modulate the immune response

doi:10.1136/emj.16.2.84